Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

90.38
Delayed Data
As of May 27
 +1.19 / +1.33%
Today’s Change
75.90
Today|||52-Week Range
143.45
-28.17%
Year-to-Date
Last Week's Best Healthcare ETF
May 28 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, T...
May 19 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Dru...
May 25 / Zacks.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate
May 20 / MotleyFool.com - Paid Partner Content
Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close89.19
Today’s open89.28
Day’s range88.37 - 90.49
Volume1,109,487
Average volume (3 months)2,388,368
Market cap$22.4B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+199.74%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book23.68

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.20+0.47%
ZTSZoetis Inc-0.15-0.32%
INCYIncyte Corp+2.75+3.36%
BMRNBiomarin Pharmaceuti...+1.83+2.10%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs